Twice daily half-dosage aspirin intake promotes equal and perhaps even more platelet inhibition when compared to standard practice of once daily

Back

ESC Premium Access

Twice daily half-dosage aspirin intake promotes equal and perhaps even more platelet inhibition when compared to standard practice of once daily

Session: Antithrombotic strategies in coronary artery disease

Topic: Thrombosis and coagulation

Speaker: Miss J. Van Diemen (Amsterdam, NL)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Miss Jeske Van Diemen

VU University Medical Centre, Amsterdam (Netherlands (The))

0 follower

9 more presentations in this session

Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Speaker: Doctor R. Wakili (Frankfurt, DE)

Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort

Speaker: Doctor Y. Yoshikawa (Kyoto, JP)

Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

Speaker: Doctor M. Bonaca (Aurora, US)

In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.

Speaker: Doctor M. Bianco (Orbassano, IT)

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

Speaker: Doctor Q. Fischer (Paris, FR)

Access the full session

Antithrombotic strategies in coronary artery disease

Speakers: Miss J. Van Diemen, Doctor R. Wakili, Doctor Y. Yoshikawa, Doctor M. Bonaca, Doctor M. Bianco...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Twice daily half-dosage aspirin intake promotes equal and perhaps even more platelet inhibition when compared to standard practice of once daily

About the speaker

Miss Jeske Van Diemen

9 more presentations in this session

Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort

Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

Access the full session

Antithrombotic strategies in coronary artery disease

About the event

ESC Congress 2017

ESC 365 is supported by